Eczema Clinical Trials

Find clinical trials for eczema. Search for eczema clinical trials in different cities and states across the United States.

Filter

Filter results

Results: 67

The Therapeutic Effects of Topical Cannabidiol (CBD) Products for Atopic DermatitisThe Therapeutic Effects of Topical Cannabidiol (CBD) Products for Atopic Dermatitis

Recruiting

Sponsor:

Phoilex Ltd.

Location:

Brampton

Code:

NCT06022874

Conditions

Atopic Dermatitis

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Phoilex Releaf Gel

A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab in Participants Aged 12 Years and Older With Moderate-to-severe Atopic Dermatitis on Background Topical CorticosteroidsA Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab in Participants Aged 12 Years and Older With Moderate-to-severe Atopic Dermatitis on Background Topical Corticosteroids

Recruiting

PHASE3

Sponsor:

Sanofi

Location:

Birmingham AL, Fort Smith AR, Encino CA, Huntington Beach CAshow 45 more

Code:

NCT06224348

Conditions

Dermatitis Atopic

Eligibility Criteria

Sex: All

Age: 12+

Healthy Volunteers: Not accepted

Interventions

Amlitelimab

Placebo

Topical corticosteroids

Topical calcineurin inhibitors

Dupilumab De-escalation in Pediatric Atopic DermatitisDupilumab De-escalation in Pediatric Atopic Dermatitis

Recruiting

Sponsor:

Johns Hopkins University

Location:

Baltimore MD

Code:

NCT06116526

Conditions

Atopic Dermatitis

Eligibility Criteria

Sex: All

Age: 1 - 17

Healthy Volunteers: Not accepted

Interventions

Dupilumab - Discontinuation

Dupilumab - Dose Reduction

Dupilumab - Standard Dose

A Longitudinal Observational Study of Patients Undergoing Therapy for IMISCA Longitudinal Observational Study of Patients Undergoing Therapy for IMISC

Recruiting

Sponsor:

Target PharmaSolutions, Inc.

Location:

Scottsdale AZ, Fort Smith AR, Little Rock AR, Fountain Valley CAshow 51 more

Code:

NCT03661866

Conditions

Atopic Dermatitis

Alopecia Areata

Hidradenitis Suppurativa

Vitiligo

Psoriasis

Eligibility Criteria

Sex: All

Age: 0 - 70+

Healthy Volunteers: Not accepted

A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab Monotherapy Compared With Placebo in Participants Aged 12 Years and Older With Moderate-to-severe Atopic DermatitisA Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab Monotherapy Compared With Placebo in Participants Aged 12 Years and Older With Moderate-to-severe Atopic Dermatitis

Recruiting

PHASE3

Sponsor:

Sanofi

Location:

Scottsdale AZ, Fountain Valley CA, Fremont CA, Lafayette CAshow 46 more

Code:

NCT06130566

Conditions

Dermatitis Atopic

Eligibility Criteria

Sex: All

Age: 12+

Healthy Volunteers: Not accepted

Interventions

Amlitelimab

Placebo

Dupixent and Narrowband UVB for Atopic DermatitisDupixent and Narrowband UVB for Atopic Dermatitis

Recruiting

Sponsor:

Psoriasis Treatment Center of Central New Jersey

Location:

East Windsor NJ

Code:

NCT05285839

Conditions

Atopic Dermatitis

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Dupixent

The Purpose of This Study is to Evaluate the Effects of Ruxolitinib Cream on Adults With Atopic Dermatitis Experiencing Sleep Disturbance.The Purpose of This Study is to Evaluate the Effects of Ruxolitinib Cream on Adults With Atopic Dermatitis Experiencing Sleep Disturbance.

Recruiting

Sponsor:

Incyte Corporation

Location:

Fountain Valley CA, Long Beach CA, Washington DC, Boca Raton FLshow 25 more

Code:

NCT05696392

Conditions

Atopic Dermatitis

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

ruxolitinib cream

Bodewell Products for the Treatment of Atopic DermatitisBodewell Products for the Treatment of Atopic Dermatitis

Recruiting

Sponsor:

University of Alabama at Birmingham

Location:

Birmingham AL

Code:

NCT05566262

Conditions

Atopic Dermatitis

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Bodewell Calming Cream

Safety, Tolerability, and Preliminary Efficacy of Soquelitinib in Participants With Moderate to Severe ADSafety, Tolerability, and Preliminary Efficacy of Soquelitinib in Participants With Moderate to Severe AD

Recruiting

PHASE1

Sponsor:

Corvus Pharmaceuticals, Inc.

Location:

Burlingame CA

Code:

NCT06345404

Conditions

Atopic Dermatitis

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Soquelitinib

Placebo

Observational Study of Canadian Patients (6 Years or Older) Receiving Dupixent® for Moderate to Severe Atopic DermatitisObservational Study of Canadian Patients (6 Years or Older) Receiving Dupixent® for Moderate to Severe Atopic Dermatitis

Recruiting

Sponsor:

Sanofi

Location:

Calgary, Edmonton, Nanaimo, Surreyshow 19 more

Code:

NCT06099704

Conditions

Moderate to Severe Atopic Dermatitis

Eligibility Criteria

Sex: All

Age: 6+

Healthy Volunteers: Not accepted